212 related articles for article (PubMed ID: 12439600)
1. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
4. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
Gorski DH; Mauceri HJ; Salloum RM; Halpern A; Seetharam S; Weichselbaum RR
Cancer Res; 2003 Jan; 63(2):308-11. PubMed ID: 12543780
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
7. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
9. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
10. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
[TBL] [Abstract][Full Text] [Related]
11. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
12. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
13. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
[TBL] [Abstract][Full Text] [Related]
14. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH
In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
[TBL] [Abstract][Full Text] [Related]
16. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Salloum RM; Jaskowiak NT; Mauceri HJ; Seetharam S; Beckett MA; Koons AM; Hari DM; Gupta VK; Reimer C; Kalluri R; Posner MC; Hellman S; Kufe DW; Weichselbaum RR
Cancer Res; 2000 Dec; 60(24):6958-63. PubMed ID: 11156396
[TBL] [Abstract][Full Text] [Related]
17. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.
te Velde EA; Vogten JM; Gebbink MF; van Gorp JM; Voest EE; Borel Rinkes IH
Br J Surg; 2002 Oct; 89(10):1302-9. PubMed ID: 12296902
[TBL] [Abstract][Full Text] [Related]
19. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]